Sat, May 25 2019

The Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a life-saving treatment for infants that will also be the the most expensive drug in the world. Known as Zolgensma, the gene therapy…

May 24 is going to go down as a big day in Novartis' 2019 highlight reel. Not only did the FDA stamp an OK on the prospective gene therapy blockbuster Zolgensma, with a record-setting $2.1 million price tag, regulators also green-lighted alpelisib…

Let the next big debate over gene therapy pricing begin now. Novartis announced midday Friday that the FDA had stamped its OK on Zolgensma, a groundbreaking gene therapy for lethal cases of spinal muscular atrophy that will test the market's…

Until last year, winning a regional spelling bee was the only way that children from across the U.S. could be invited to—and win—the annual Scripps National Spelling Bee, an iconic scholastic competition held since 1925. Then…